Published in Clin Microbiol Rev on January 01, 2005
Transfusion-transmitted infections. J Transl Med (2007) 1.39
Reducing noninfectious risks of blood transfusion. Anesthesiology (2011) 1.30
Colorimetric bacteria sensing using a supramolecular enzyme-nanoparticle biosensor. J Am Chem Soc (2011) 1.16
Novel and unexpected clearance mechanisms for cold platelets. Transfus Apher Sci (2009) 1.08
Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light. Transfus Med Hemother (2011) 1.05
Psychrobacter arenosus bacteremia after blood transfusion, France. Emerg Infect Dis (2013) 1.02
Reduction of the risk of bacterial contamination of blood components through diversion of the first part of the donation of blood and blood components. Blood Transfus (2009) 0.96
Design of a new therapy to treat snake envenomation. Drug Des Devel Ther (2014) 0.95
Comparison of the BACTEC 9240 and BacT/Alert blood culture systems for detection of bacterial contamination in platelet concentrates. J Clin Microbiol (2006) 0.89
UVC Irradiation for Pathogen Reduction of Platelet Concentrates and Plasma. Transfus Med Hemother (2011) 0.89
A signaling pathway contributing to platelet storage lesion development: targeting PI3-kinase-dependent Rap1 activation slows storage-induced platelet deterioration. Transfusion (2009) 0.84
Comparison of the Bactec 9240 and BacT/Alert blood culture systems for evaluation of placental cord blood for transfusion in neonates. J Clin Microbiol (2009) 0.83
Bacterial screening of platelet concentrates on day 2 and 3 with flow cytometry: the optimal sampling time point? Blood Transfus (2014) 0.83
The Pan Genera Detection immunoassay: a novel point-of-issue method for detection of bacterial contamination in platelet concentrates. J Clin Microbiol (2010) 0.82
Pseudomonas fluorescens contamination of a feline packed red blood cell unit and studies of canine units. Vet Clin Pathol (2009) 0.82
Implementation of Bacterial Detection Methods into Blood Donor Screening - Overview of Different Technologies. Transfus Med Hemother (2011) 0.81
Laboratory Evaluation of the Effectiveness of Pathogen Reduction Procedures for Bacteria. Transfus Med Hemother (2011) 0.81
Bacterial culture reduces but does not eliminate the risk of septic transfusion reactions to single-donor platelets. Transfusion (2009) 0.81
Bacterial contamination of donor blood at the Tamale Teaching Hospital, Ghana. Afr Health Sci (2009) 0.81
Bartonella henselae transmission by blood transfusion in mice. Transfusion (2016) 0.80
Bacteriological safety of blood collected for transfusion at university of gondar hospital blood bank, northwest ethiopia. ISRN Hematol (2013) 0.79
A Dormant Microbial Component in the Development of Preeclampsia. Front Med (Lausanne) (2016) 0.76
Blood conservation strategies in orthopedic surgeries: A review. J Clin Orthop Trauma (2013) 0.76
Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination. J Vis Exp (2015) 0.75
A fatal case of post-transfusion sepsis caused by Yersinia enterocolitica after delivery. Blood Transfus (2015) 0.75
From the donor's arm to blood product: a study on bacterial contamination of apheresis platelet concentrates. Blood Transfus (2007) 0.75
Performance evaluation of the VersaTREK blood culture system for quality control testing of platelet units. J Clin Microbiol (2009) 0.75
Bacterial contamination of platelet products in the Blood Transfusion Center of Isfahan, Iran. GMS Hyg Infect Control (2016) 0.75
An Internal Reference Control Duplex Real-Time Polymerase Chain Reaction Assay for Detecting Bacterial Contamination in Blood Products. PLoS One (2015) 0.75
Evaluation of Mirasol pathogen reduction system by artificially contaminating platelet concentrates with Staphylococcus epidermidis: A pilot study from India. Asian J Transfus Sci (2016) 0.75
Prevalence of Bacterial Contamination when using a Diversion Pouch during Blood Collection: A Single Center Study in Malaysia. Malays J Med Sci (2014) 0.75
Septic shock during platelet transfusion in a patient with acute myeloid leukaemia. BMJ Case Rep (2013) 0.75
INVESTIGATION OF BIOFILM FORMATION IN COAGULASE-NEGATIVE STAPHYLOCOCCI ISOLATED FROM PLATELET CONCENTRATE BAGS. Rev Inst Med Trop Sao Paulo (2016) 0.75
A New Proof of Concept in Bacterial Reduction: Antimicrobial Action of Violet-Blue Light (405 nm) in Ex Vivo Stored Plasma. J Blood Transfus (2016) 0.75
Evaluation of the Sensitivity and Specificity of Use of Glucose and pH for Bacterial Screening of Platelet Concentrates Compared to the Bact/Alert. Indian J Hematol Blood Transfus (2016) 0.75
Transfusion transmitted diseases in perioperative and intensive care settings. Indian J Anaesth (2014) 0.75
Does the low prevalence of bacterial contamination in random platelet concentrates justify the use of preventive measures? Rev Bras Hematol Hemoter (2013) 0.75
Stored Canine Whole Blood Units: What is the Real Risk of Bacterial Contamination? J Vet Intern Med (2016) 0.75
Introducing Pathogen Reduction Technology in Poland: A Cost-Utility Analysis. Transfus Med Hemother (2015) 0.75
Single passage in mouse organs enhances the survival and spread of Salmonella enterica. J R Soc Interface (2015) 0.75
Improved amplification of microbial DNA from blood cultures by removal of the PCR inhibitor sodium polyanetholesulfonate. J Clin Microbiol (1998) 3.38
Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med (2003) 3.37
Transfusion medicine: looking to the future. Lancet (2003) 2.70
Sepsis associated with transfusion of red cells contaminated with Yersinia enterocolitica. Transfusion (1990) 2.13
Single-donor platelets reduce the risk of septic platelet transfusion reactions. Transfusion (2001) 1.94
Seven-day storage of single-donor platelets: recovery and survival in an autologous transfusion study. Transfusion (2002) 1.92
Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion (2001) 1.81
Evaluation of donor skin disinfection methods. Transfusion (1997) 1.71
Nosocomial epidemic of Serratia marcescens septicemia ascribed to contaminated blood transfusion bags. Transfusion (1993) 1.70
Does blood of healthy subjects contain bacterial ribosomal DNA? J Clin Microbiol (2001) 1.54
Screening blood donors for gastrointestinal illness: a strategy to eliminate carriers of Yersinia enterocolitica. Transfusion (1991) 1.52
Determinants of transfusion-associated bacterial contamination: results of the French BACTHEM Case-Control Study. Transfusion (2001) 1.47
The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion (2003) 1.41
Direct real-time PCR quantification of Campylobacter jejuni in chicken fecal and cecal samples by integrated cell concentration and DNA purification. Appl Environ Microbiol (2004) 1.35
Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. Blood (2004) 1.31
Rapid identification of Yersinia enterocolitica in blood by the 5' nuclease PCR assay. J Clin Microbiol (2000) 1.22
Evaluation of a new generation of culture bottle using an automated bacterial culture system for detecting nine common contaminating organisms found in platelet components. Transfusion (2002) 1.22
Evaluation of an automated culture system for detecting bacterial contamination of platelets: an analysis with 15 contaminating organisms. Transfusion (2001) 1.18
Fatal Clostridium perfringens sepsis from a pooled platelet transfusion. Transfus Med (1998) 1.17
Growth of bacteria in inoculated platelets: implications for bacteria detection and the extension of platelet storage. Transfusion (2000) 1.12
Transfusion-related sepsis due to Serratia liquefaciens in the United States. Transfusion (2000) 1.11
Diversion of first blood volume results in a reduction of bacterial contamination for whole-blood collections. Vox Sang (2002) 1.02
Detection of bacteria in WBC-reduced PLT concentrates using percent oxygen as a marker for bacteria growth. Transfusion (2003) 1.01
A prospective study of symptomatic bacteremia following platelet transfusion and of its management. Transfusion (1994) 1.00
Evaluation of donor arm disinfection techniques. Vox Sang (2001) 0.99
Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma. Semin Hematol (2001) 0.99
Skin fragments removed by injection needles. Lancet (1958) 0.99
Operating theatre water-baths as a cause of pseudomonas septicaemia. J Hosp Infect (1981) 0.97
Platelet bacterial contamination and the use of a chemiluminescence-linked universal bacterial ribosomal RNA gene probe. Transfusion (1994) 0.96
Interim measures for detection of bacterially contaminated red cell components. Transfusion (1992) 0.96
Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function. Vox Sang (2000) 0.95
Evaluation of the 3D BacT/ALERT automated culture system for the detection of microbial contamination of platelet concentrates. Transfus Med (2002) 0.93
Monitoring of apheresis platelet bacterial contamination with an automated liquid culture system: a university experience. Transfusion (2003) 0.92
Rapid identification of bacterially contaminated platelets using reagent strips: glucose and pH analysis as markers of bacterial metabolism. Transfusion (1997) 0.92
Update: Yersinia enterocolitica bacteremia and endotoxin shock associated with red blood cell transfusions--United States, 1991. MMWR Morb Mortal Wkly Rep (1991) 0.92
Efficacy of a new collection procedure for preventing bacterial contamination of whole-blood donations. Transfusion (2001) 0.91
Salmonella septicemia from platelet transfusions. Study of an outbreak traced to a hematogenous carrier of Salmonella cholerae-suis. Ann Intern Med (1973) 0.90
A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets. Transfusion (1994) 0.90
Bacterial contamination of blood components. Vox Sang (2000) 0.90
Growth and survival of Serratia marcescens under aerobic and anaerobic conditions in the presence of materials from blood bags. J Clin Microbiol (1993) 0.88
Detecting bacteria in platelet concentrates by use of reagent strips. Transfusion (2002) 0.86
Transfusion-related sepsis after prolonged platelet storage. Am J Med (1986) 0.86
Evaluation of swirling, pH, and glucose tests for the detection of bacterial contamination in platelet concentrates. Transfusion (1996) 0.86
Evaluation of a new generation of plastic culture bottles with an automated microbial detection system for nine common contaminating organisms found in PLT components. Transfusion (2004) 0.85
Transfusion transmitted Yersinia enterocolitica infection in New Zealand. Aust N Z J Med (1997) 0.84
Red blood cell transfusions contaminated with Yersinia enterocolitica--United States, 1991-1996, and initiation of a national study to detect bacteria-associated transfusion reactions. MMWR Morb Mortal Wkly Rep (1997) 0.84
Salmonella sepsis caused by a platelet transfusion from a donor with a pet snake. N Engl J Med (2002) 0.83
A retrospective analysis of microbial contaminants in outdated random-donor platelets from multiple sites. Transfusion (1997) 0.82
Posttransfusion Serratia marcescens septicemia. Transfusion (1993) 0.81
Operational feasibility of routine bacterial monitoring of platelets. Transfus Med (2003) 0.80
[Bacterial contamination of platelet concentrates by Propionibacterium acnes]. Transfus Clin Biol (2000) 0.80
The use of a chemiluminescence-linked universal bacterial ribosomal RNA gene probe and blood gas analysis for the rapid detection of bacterial contamination in white cell-reduced and nonreduced platelets. Transfusion (1993) 0.79
Glucose and haemolysis as a rapid screen for contamination of red blood cells with Yersinia and Serratia. Vox Sang (2001) 0.79
Greetings--a final look back with comments about a policy of a zero-risk blood supply. Transfusion (1987) 0.79
"Creeping precautionism" and the blood supply. Transfusion (2003) 0.78
Investigation of an isolate of Staphylococcus lugdunensis implicated in a platelet fatality: a possible advantage of the use of an anaerobic bottle. Transfusion (2007) 1.11
Is it HIV TTP or HIV-associated thrombotic microangiopathy? J Clin Apher (2008) 0.97
Thrombotic thrombocytopenic purpura and urinary tract infections: is there a connection? Am J Clin Pathol (2011) 0.92
Transfusion medicine illustrated. Platelet swirling. Transfusion (2004) 0.87
Frequency and significance of schistocytes in TTP/HUS patients at the discontinuation of plasma exchange therapy. J Clin Apher (2004) 0.84
Is it quinine TTP/HUS or quinine TMA? ADAMTS13 levels and implications for therapy. J Clin Apher (2009) 0.84
ABO blood type and longevity. Am J Clin Pathol (2011) 0.83
ADAMTS13 activity levels in patients with human immunodeficiency virus-associated thrombotic microangiopathy and profound CD4 deficiency. J Clin Apher (2009) 0.81
Extended storage of AS-1 and AS-3 leukoreduced red blood cells for 15 days after deglycerolization and resuspension in AS-3 using an automated closed system. Transfusion (2004) 0.79
Successful in vivo recovery and extended storage of additive solution (AS)-5 red blood cells after deglycerolization and resuspension in AS-3 for 15 days with an automated closed system. Transfusion (2007) 0.79
Modeling of bacterial contamination. Transfusion (2008) 0.75
Fatal streptococcal infection despite routine bacterial culture screening. Transfusion (2008) 0.75
Validation of pH and glucose determination for bacteria detection screening in platelet concentrates stored in the Terumo Teruflex XT612 platelet container. Transfusion (2004) 0.75
Validation of a microbial detection system for use with ACD-A platelets with PAS III platelet additive solution. Transfusion (2011) 0.75
Improving platelet safety: bacterial contamination of platelets. Curr Hematol Rep (2004) 0.75
Theoretical efficacy of using albumin/plasma versus full plasma replacement in TTP. J Clin Apher (2010) 0.75
Transfusion medicine illustrated. Pseudohemolysis with iron dextran therapy. Transfusion (2002) 0.75
Analytical performance of RNA isolated from BD SurePath™ cervical cytology specimens by the PreTect™ HPV-Proofer assay. J Virol Methods (2012) 0.75
Platelet senescent cultures and the predictive value of an early culture. Transfusion (2006) 0.75